- Report
- October 2021
- 208 Pages
Global
From €3051EUR$3,185USD£2,598GBP
€4358EUR$4,550USD£3,711GBP
- Report
- February 2024
- 80 Pages
Germany
From €4550EUR$4,750USD£3,874GBP
- Report
- April 2023
- 110 Pages
Global
From €4550EUR$4,750USD£3,874GBP
- Report
- May 2020
- 112 Pages
Global
From €4550EUR$4,750USD£3,874GBP
- Report
- July 2021
- 105 Pages
Global
From €4550EUR$4,750USD£3,874GBP
- Report
- January 2024
- 102 Pages
From €2380EUR$2,485USD£2,027GBP
€3400EUR$3,550USD£2,895GBP
- Report
- July 2021
- 168 Pages
Europe
From €2011EUR$2,100USD£1,713GBP
€2873EUR$3,000USD£2,447GBP
- Report
- November 2020
- 350 Pages
Global
From €3051EUR$3,185USD£2,598GBP
€4358EUR$4,550USD£3,711GBP
- Report
- March 2020
- 179 Pages
Global
From €3051EUR$3,185USD£2,598GBP
€4358EUR$4,550USD£3,711GBP
- Report
- August 2022
- 113 Pages
Global
From €4310EUR$4,500USD£3,670GBP
- Report
- April 2023
- 115 Pages
Global
From €4310EUR$4,500USD£3,670GBP
- Report
- September 2018
- 92 Pages
Global
From €4550EUR$4,750USD£3,874GBP
- Report
- February 2022
- 40 Pages
India
From €2485EUR$2,595USD£2,117GBP
- Report
- February 2022
- 40 Pages
Saudi Arabia
From €2485EUR$2,595USD£2,117GBP
- Report
- March 2020
- 100 Pages
Global
From €4593EUR$4,795USD£3,911GBP
- Report
- December 2022
- 116 Pages
Global
From €3831EUR$4,000USD£3,263GBP
- Report
- June 2021
Global
From €7183EUR$7,500USD£6,117GBP
- Report
- June 2021
Global
From €7183EUR$7,500USD£6,117GBP
- Report
- June 2021
Global
From €7183EUR$7,500USD£6,117GBP
- Report
- June 2021
Global
From €7183EUR$7,500USD£6,117GBP
The Nucleic Acid Amplification (NAA) market within the In Vitro Diagnostics (IVD) industry is a rapidly growing segment. NAA is a technique used to detect and quantify nucleic acids, such as DNA and RNA, from a variety of sources. It is used in a wide range of applications, including clinical diagnostics, food safety testing, and environmental monitoring. NAA is a highly sensitive and specific method for detecting and quantifying nucleic acids, and is increasingly being used in IVD applications.
NAA technology is used in a variety of IVD tests, including infectious disease testing, genetic testing, and cancer diagnostics. It is also used in the development of new diagnostic tests, such as those for emerging infectious diseases. NAA technology is also being used in the development of personalized medicine, allowing for the detection of genetic mutations that may be associated with certain diseases.
The NAA market is expected to continue to grow in the coming years, driven by the increasing demand for IVD tests and the development of new technologies. Major players in the NAA market include Roche Diagnostics, Abbott Laboratories, Becton Dickinson, Qiagen, and Thermo Fisher Scientific. Show Less Read more